PharmaBoardroom’s interview with President Stephan Eder

18 February 2025

President of Medicines for Europe, Stephan Eder, highlights the association’s […]

Biosimilar medicines: the intersection of access, affordability, and innovation

3 February 2025

Director of Biosimilar Policy & Science at Medicines for Europe, […]

Building A Sustainable Market: new Medicines for Europe President sets out priorities

20 January 2025

Newly appointed Medicines for Europe President Stephan Eder discusses the […]

Elisabeth Stampa: ‘Many drugs that used to be produced in Europe are now manufactured in Asia. This makes us vulnerable to shortages’

2 September 2024

The president of Medicines for Europe considers that the supply […]

The enormous and unknown healing power of old medicines (ES)

11 March 2024

The legislative reform being prepared by the EU plans to […]

Health Policy Watch: Forum Discusses High Drug Prices in Wealthy Countries and Access to Medicines in Conflicts

12 February 2024

Adrian van den Hoven, chair of the International Generic and […]

New pricing models for generic medicines to ensure long-term sustainable competition in Europe

10 October 2023

Background: Price erosion of generic medicines over time as a […]

(LT) Lithuanian Government – Vyriausybės kanclerė aptarė vaistų tiekimo ir prieinamumo klausimus su „Medicine for Europe“ generaliniu direktoriumi

23 August 2023

Antradienį Vyriausybės kanclerė Giedrė Balčytytė susitiko su organizacijos „Medicine for […]

(IT) Healthcare Policy – Autonomia strategica nel Pharma. Serve un’azione politica

26 June 2023

TVM News – Malta agrees on a common medicines market in the EU

19 June 2023

Malta agrees with the European Commission’s legislative proposals to improve […]